Sign inJoin waitlistJoin the waitlist

Daniel Burdick

Physician · Evergreen Hospital Medical Center

Credentials: · · · ·

History

Select Outpatient Services Inc
2025–Present

EvergreenHealth
2011–2013
University of Washington School of Medicine
2010–2011
Neurology
Beth Israel Deaconess Medical Center
2006–2010
Johns Hopkins Univ Sch of Med
2002–2006

Research

Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations
Science Translational Medicine · 2012 · 307 citations
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
The Lancet Neurology · 2024 · 126 citations
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors
Journal of Medicinal Chemistry · 2012 · 121 citations

PA
Pinky Agarwal
4 papers
RG
Ramon Gil
3 papers
Rohit Dhall
3 papers
AG
Alida Griffith
2 papers
Andrew McGarry
2 papers
CO
C. Olanow
2 papers
Cyrus Zabetian
2 papers
David Shprecher
2 papers
James Leverenz
2 papers
Joseph Quinn
2 papers
Karl Kieburtz
2 papers
KK
Kevin Klos
2 papers

Clinical trials

A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
Principal investigator · Completed · Phase 4
Burdick, Daniel, M.D.
2016–2022
A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)
Principal investigator · Completed · Phase 4
Daniel Burdick, MD
2014–2018